CN Patent

CN102379684B — 药物信息系统

Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2014-11-19 · 11y expired

What this patent protects

本发明提供了允许检测药物制剂实际内服药物释放到体内的组合物、系统和方法。这些组合物的实施方案包括识别器和活性剂。本发明发现在各种不同的应用中，包括但不限于监控治疗方案的依从性、跟踪药物制剂的历史等中的用途。

USPTO Abstract

本发明提供了允许检测药物制剂实际内服药物释放到体内的组合物、系统和方法。这些组合物的实施方案包括识别器和活性剂。本发明发现在各种不同的应用中，包括但不限于监控治疗方案的依从性、跟踪药物制剂的历史等中的用途。

Drugs covered by this patent

Abilify (aripiprazole) · Generic (originally Otsuka/BMS)

Patent Metadata

Patent number: CN102379684B
Jurisdiction: CN
Classification: —
Expires: 2014-11-19
Drug substance claim: No
Drug product claim: No
Assignee: Otsuka Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.